Adial Pharmaceuticals Finalizes Separation Agreement With Dr. Johnson

TipRanksApr 27 04:13

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC

BenzingaApr 25 20:06

EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent

Yahoo FinanceApr 22 22:00

Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder

Adial Pharmaceuticals (ADIL) said Monday it has been granted a US patent covering the combination of its proprietary genetic diagnostic and its lead Investigational New Drug AD04 to treat alcohol use

MT NewswiresApr 22 21:12

Adial Pharmaceuticals Granted Key Patent From the United States Patent and Trademark Office

GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and

GlobeNewswireApr 22 20:30

EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'This Patent Expands Adial's Intellectual Property Protection and Covers the Combination of the Company's Proprietary Genetic Diagnostic to Identify Patients With Specific Genotypes

EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'This Patent Expands Adial's Intellectual Property Protection and Covers the Combination of the Company's Proprietary Genetic Diagnostic to Identify Pat

BenzingaApr 22 20:00